Guillaume Grolez

Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease

David Devos, Caroline Moreau, Jean Christophe Devedjian et al. · Antioxidants and Redox Signaling · 2013 · 613 citations · Full text

Medicine, Neurology, Pharmacology +17

Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?© Caroline Moreau <i>et al</i> . 2018; Published by Mary Ann Liebert, Inc. This Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Caroline Moreau, Véronique Danel, Jean Christophe Devedjian et al. · Antioxidants and Redox Signaling · 2017 · 108 citations · Full text

Medicine, Neurology, Neuroscience +17

Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease

Guillaume Grolez, Caroline Moreau, Bernard Sablonnière et al. · BMC Neurology · 2015 · 101 citations · Full text

Medicine, Neurology, Neuroscience +14

Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?

Lucie Hopes, Guillaume Grolez, Caroline Moreau et al. · PLoS ONE · 2016 · 83 citations · Full text

Medicine, Neurology, Neuroscience +17

TMEM240 mutations cause spinocerebellar ataxia 21 with mental retardation and severe cognitive impairment

Jérôme Delplanque, David Devos, Vincent Huin et al. · Brain · 2014 · 69 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17